Impact of discordant revised versus molecular international prognostic scoring system risk in myelodysplastic
Alexandre Bazinet1, Guillermo Montalban-Bravo2, Alex Bataller2
1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. abazinet@mdanderson.org.
Leukemia
|September 5, 2025
Abstract
No abstract available in PubMed .


